5Ferreira MA. Cytokine expression in allergic inflammation:. systematic review of in vivo challenge studies. Mediators Inflamm, 2003 ; 12 (5) : 259-267.
6Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, et al. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett,1997,57(1-3):117-120.
7Sharp JT, Young DY, Bluhm GB, et al. How mang joints in thehandsand wrists should be included in a score of radiologic abnormalities usedto- assess rheumatoid arthritis. Arthritis Rheum, 1985 ,28 (6) : 1326-1335.
8American college of rheumatology committee to reevaluate imp rove2ment criteria. A proposed revision to the ACR20: hybrid measure of american college of rheumatology response. Arthritis Rheum,2007,57(2) :193-202.
9Aletaha D, Nell VPK, Stamm T, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis : validation of a clinical activity score. Arthritis Res Ther,2005 ;7(4) :796-806.
10Haringman JJ, Smeets TJ, Reinders-Blankert P, et al. Chemokine and chemokine receptor expression in pairedperipheral blood mononuclear cells and synovial tissue of rheumatoid arthritis, osteoarthritis and reactive arthritis patients. Ann Rheum Dis,2006;65(3) :294-300.
